Bioequivalence testing guideline for combination drugs to be made public
Published: 2010-03-09 06:59:00
Updated: 2010-03-09 06:59:00
The Korea Food and Drug Administration is considering formulating a detailed rule concerning bioequivalence testing of combined preparations after consultation with the industry, as the bioequivalence testing for combination drugs become mandatory from this year.
The drug agency noted that in ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
